Are Stephen Hahn’s days numbered at FDA?

By Chris Newmarker | October 22, 2020

FDA Commissioner Dr. Stephen Hahn

HHS Secretary Alex Azar has been reportedly discussing the removal of Dr. Stephen Hahn as FDA commissioner, according to Politico.

The Politico report cited a half dozen current and former administration officials.

FDA spokesperson Michael Felberbaum in an email to Drug Discovery‘s sister site MassDevice denied an Azar-Hahn feud: “Commissioner Hahn enjoys a good relationship with Secretary Azar and speaks with him regularly.”

Politico‘s claim of a potential Hahn ouster comes after FDA openly defied President Donald Trump by telling COVID-19 vaccine developers that the agency needs two months’ worth of safety data before it will consider emergency approvals.

Get the full story on MassDevice.

Filed Under: Drug Discovery, Infectious Disease
Tagged With: Dr. Stephen Hahn, FDA, HHS

About The Author

Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.